Argenica Therapeutics LtdASX: AGN

ARG-007 Phase 2 Clinical Trial Update

Jul 19, 2023 at 2:43 AM UTC · Issued by Argenica Therapeutics Ltd

Argenica Therapeutics Ltd has released a press release.

View Attachment